Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
547,132
Value
$341.2M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of REGN by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026547,132$341.2M0.2%+200,277+57.7%AddedHolders
Q1 2026346,855$268.0M0.2%+141,123+68.6%AddedHolders
Q4 2025205,732$158.8M0.1%+7,475+3.8%AddedHolders
Q3 2025198,257$111.5M0.1%+14,213+7.7%AddedHolders
Q2 2025184,044$96.6M0.1%+70,124+61.6%AddedHolders
Q1 2025113,920$72.3M0.1%−158,672−58.2%ReducedHolders
Q4 2024272,592$194.2M0.2%−19,349−6.6%ReducedHolders
Q3 2024291,941$306.9M0.3%−70,364−19.4%ReducedHolders
Q2 2024362,305$380.8M0.4%+25,833+7.7%AddedHolders
Q1 2024336,472$323.9M0.3%−29,478−8.1%ReducedHolders
Q4 2023365,950$321.4M0.4%+195,902+115.2%AddedHolders
Q3 2023170,048$139.9M0.2%+8,430+5.2%AddedHolders
Q2 2023161,618$116.1M0.1%−62,057−27.7%ReducedHolders
Q1 2023223,675$183.8M0.2%+23,995+12.0%AddedHolders
Q4 2022199,680$144.1M0.2%−253,607−55.9%ReducedHolders
Q3 2022453,287$312.3M0.4%+54,716+13.7%AddedHolders
Q2 2022398,571$235.6M0.3%+225,696+130.6%AddedHolders
Q1 2022172,875$120.7M0.1%−30,812−15.1%ReducedHolders
Q4 2021203,687$128.6M0.1%+5,969+3.0%AddedHolders
Q3 2021197,718$119.7M0.1%+25,468+14.8%AddedHolders
Q2 2021172,250$96.2M0.1%−1,807−1.0%ReducedHolders
Q1 2021174,057$82.4M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.